Respiro
Board
1 director, no change since 2022Director (not named in the articles)
since 14-10-2014
earlier director, until 29-08-2022
listed in the 2025 annual accounts, filed on 18-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 29-08-2022
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), from 14-10-2014 to date
- Director, until 29-08-2022
With Starter you also see 1 former office holder in the mandate history.
See the plans →
Control
Founder
This company
Respiro
Equity €104,258
Profit €428,177 in 2025
Capital
- Capital
- €18,550
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €1,043 in 2025
- Source
- deed of 06-01-2017
Articles of association
deed of 29-08-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Enkel niet-medische aangelegenheden, benoeming voldoende gemotiveerd schriftelijk ter goedkeuring aan de Raad voorgelegd
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00
Founder
At incorporation
deed of 21-10-2014 ↗
- sole founder · 100% at incorporation
Capital transactions
Capital over time
- 29-08-2022 Capital stated in the deed · 100 shares
- 06-01-2017 Capital increase of €15,550 · to €18,550 · no new shares · in cash
- 21-10-2014 Incorporation · €3,000 · 100 shares